Revelation Biosciences Share Price (NASDAQ: REVB)
$2.75
Last updated on
Check the interactive Revelation Biosciences Stock chart to analyse performance
Revelation Biosciences stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$2.73Today's High:$2.79
0.73%
Downside
Day's Volatility :2.15%
Upside
1.43%
- 52 Weeks Low:$2.1152 Weeks High:$60.48
23.42%
Downside
52 Weeks Volatility :96.52%
Upside
95.45%
Revelation Biosciences Stock Returns
Revelation Biosciences Inc Key Stats
Check Revelation Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Revelation Biosciences Stock including INR - Dollar returns
The Revelation Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Revelation Biosciences investment value today
Current value as on today
₹10,689
Returns
Returns from Revelation Biosciences Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Revelation Biosciences Stock
Global Institutional Holdings in Revelation Biosciences Inc
Name
Holdings %
Tower Research Capital LLC
0.04%
Royal Bank of Canada
0.03%
SBI Securities Co Ltd
0.01%
UBS Group AG
0.01%
IFP Advisors, LLC
0.01%
Analyst Recommendation on Revelation Biosciences Stock
Buy
85%Buy
14%Hold
0%Sell
Based on 7 Wall street analysts offering stock ratings for Revelation Biosciences(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Revelation Biosciences Share Price Target
What analysts predicted
Upside of 2081.82%
Target:
$60.00
Current:
$2.75
Revelation Biosciences share price target is $60.00, a slight Upside of 2081.82% compared to current price of $2.75 as per analysts' prediction.
Revelation Biosciences Stock Insights
Price Movement
In the last 7 days, REVB stock has moved down by -6.8%REVB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 165.0%REVB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.6%
Revelation Biosciences Technicals Summary
Sell
Neutral
Buy
Revelation Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Revelation Biosciences Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 9.64% | -73.93% | -94.63% | -99.99% | -100.0% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.0 | 0.0 | NA | -12.12 | -3.41 | -0.57 | NA | 2.49 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $4.7M | -100.0% | 0.0 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Revelation Biosciences Inc
Key Management of Revelation Biosciences Inc
Important FAQs about investing in REVB Stock from India :
What is Revelation Biosciences share price today?
Revelation Biosciences share price today is $2.75 as on at the close of the market. Revelation Biosciences share today touched a day high of $2.79 and a low of $2.73.
What is the 52 week high and 52 week low for Revelation Biosciences share?
Revelation Biosciences share touched a 52 week high of $60.48 and a 52 week low of $2.11. Revelation Biosciences stock price today i.e. is closed at $2.75, lower by 95.45% versus the 52 week high.
How to invest in Revelation Biosciences Stock (REVB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Revelation Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Revelation Biosciences Shares that will get you 0.5455 shares as per Revelation Biosciences share price of $2.75 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Revelation Biosciences Stock (REVB) from India?
Indian investors can start investing in Revelation Biosciences (REVB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Revelation Biosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Revelation Biosciences share’s latest price of $2.75 as on August 30, 2025 at 1:29 am IST, you will get 3.6364 shares of Revelation Biosciences. Learn more about
fractional shares .
What are the returns that Revelation Biosciences has given to Indian investors in the last 5 years?
Revelation Biosciences stock has given -100.0% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%